The structures of two polysaccharides from Angelica sinensis and their effects on hepatic insulin resistance through blocking RAGE

Carbohydr Polym. 2022 Mar 15:280:119001. doi: 10.1016/j.carbpol.2021.119001. Epub 2021 Dec 13.

Abstract

This study found two novel homogeneous polysaccharides from Angelica sinensis, APS-1I and APS-2II, binding to RAGE with a dissociation constant of 2.02 ± 0.2 and 85.92 ± 0.2 μM, respectively. APS-1I is a 17.0 kDa heteropolysaccharide, whose backbone is composed of α-1,6-Glcp, α-1,3,6-Glcp, α-1,2-Glcp, α-1,4-Galp, and α-1,3-Rhap, and whose two branches contain α-1,3,5-Araf, α-1,3-Araf, α-1,4-Galp, β-1,3-Galp, and β-1,4-Glcp. APS-2II is a 10.0 kDa linear glucan, that contains α-1,6-Glcp, α-1,3-Glcp, α-1,2-Glcp, and α-T-Glcp. In vitro, APS-1I demonstrated better promotion on glucose absorption and stronger repression on p-IRS-1 (Ser307), p-IRS-2 (Ser731), p-JNK, and p-P38 than APS-2II in insulin resistance (IR)-HepG2 cells. Furthermore, APS-1I treatment couldn't further decrease the inhibition on the phosphorylation of JNK and P38 produced by RAGE siRNA in IR-HepG2 cells. In vivo, APS-1I markedly improved IR and reversed the livers RAGE-JNK/p38-IRS signaling in high-fat-diet and streptozotocin-induced diabetic rats, suggesting that APS-1I could be a potential agent for improving IR in type 2 diabetes.

Keywords: Angelica sinensis; Insulin resistance; Polysaccharide; Structure; Type 2 diabetes.

MeSH terms

  • Angelica sinensis / chemistry*
  • Animals
  • Carbohydrate Sequence
  • Diabetes Mellitus, Type 2 / metabolism
  • Glucose / metabolism
  • Hep G2 Cells
  • Humans
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology
  • Insulin / metabolism
  • Insulin Receptor Substrate Proteins / metabolism
  • Insulin Resistance*
  • Janus Kinases / metabolism
  • Liver / drug effects
  • Liver / metabolism*
  • MAP Kinase Signaling System
  • Male
  • Polysaccharides / chemistry*
  • Polysaccharides / metabolism
  • Polysaccharides / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptor for Advanced Glycation End Products / antagonists & inhibitors
  • Receptor for Advanced Glycation End Products / metabolism*
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • AGER protein, human
  • Ager protein, rat
  • Hypoglycemic Agents
  • Insulin
  • Insulin Receptor Substrate Proteins
  • Polysaccharides
  • Receptor for Advanced Glycation End Products
  • Janus Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Glucose